MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Hospital Universitario 12 Octubre Avda. de Córdoba
Madrid, Spain
- Start Madrid-Fjd, Fundación Jimѐnez Díaz
Madrid, Spain
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University - School of Medicine
St Louis, Missouri, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Tennessee Oncology - Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Vanderbilt - Ingram Cancer Center
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2016
- Primary completion
- 18 Dec 2019
- Completion
- 4 Jun 2020
- Last update posted
- 4 Feb 2026
- Registered enrollment
- 10
- Registry id
- NCT02989064
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.